Novel dosing strategy of omalizumab during multi-allergen oral-immunotherapy

Novel dosing strategy of omalizumab during multi-allergen oral-immunotherapy

Bibliographic Details
Main Authors: Sayantani B. Sindher, Andrew Long, Natasha Purington, Divya Kumar, Stacey Skura, Margaret A. Woch, Tiffany Tan, Andres Alvarez, R. Sharon Chinthrajah, Maria Garcia-Lloret, Kari C. Nadeau
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:World Allergy Organization Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455120303185
id doaj-1d24c75af1104ec0bebeaac4271afda4
record_format Article
spelling doaj-1d24c75af1104ec0bebeaac4271afda42020-11-25T02:42:03ZengElsevierWorld Allergy Organization Journal1939-45512020-08-01138100415Novel dosing strategy of omalizumab during multi-allergen oral-immunotherapySayantani B. Sindher0Andrew Long1Natasha Purington2Divya Kumar3Stacey Skura4Margaret A. Woch5Tiffany Tan6Andres Alvarez7R. Sharon Chinthrajah8Maria Garcia-Lloret9Kari C. Nadeau10Stanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USAStanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USAStanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USAStanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USAUCLA - School of Medicine, Division of Allergy, Immunology & Rheumatology, Department of Pediatrics David Geffen, Los Angeles, CA, USAStanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USAStanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USAStanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USAStanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USAUCLA - School of Medicine, Division of Pediatric Allergy/Immunology and Rheumatology, Department of Pediatrics, Los Angeles, CA, USAStanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USAhttp://www.sciencedirect.com/science/article/pii/S1939455120303185
collection DOAJ
language English
format Article
sources DOAJ
author Sayantani B. Sindher
Andrew Long
Natasha Purington
Divya Kumar
Stacey Skura
Margaret A. Woch
Tiffany Tan
Andres Alvarez
R. Sharon Chinthrajah
Maria Garcia-Lloret
Kari C. Nadeau
spellingShingle Sayantani B. Sindher
Andrew Long
Natasha Purington
Divya Kumar
Stacey Skura
Margaret A. Woch
Tiffany Tan
Andres Alvarez
R. Sharon Chinthrajah
Maria Garcia-Lloret
Kari C. Nadeau
Novel dosing strategy of omalizumab during multi-allergen oral-immunotherapy
World Allergy Organization Journal
author_facet Sayantani B. Sindher
Andrew Long
Natasha Purington
Divya Kumar
Stacey Skura
Margaret A. Woch
Tiffany Tan
Andres Alvarez
R. Sharon Chinthrajah
Maria Garcia-Lloret
Kari C. Nadeau
author_sort Sayantani B. Sindher
title Novel dosing strategy of omalizumab during multi-allergen oral-immunotherapy
title_short Novel dosing strategy of omalizumab during multi-allergen oral-immunotherapy
title_full Novel dosing strategy of omalizumab during multi-allergen oral-immunotherapy
title_fullStr Novel dosing strategy of omalizumab during multi-allergen oral-immunotherapy
title_full_unstemmed Novel dosing strategy of omalizumab during multi-allergen oral-immunotherapy
title_sort novel dosing strategy of omalizumab during multi-allergen oral-immunotherapy
publisher Elsevier
series World Allergy Organization Journal
issn 1939-4551
publishDate 2020-08-01
url http://www.sciencedirect.com/science/article/pii/S1939455120303185
work_keys_str_mv AT sayantanibsindher noveldosingstrategyofomalizumabduringmultiallergenoralimmunotherapy
AT andrewlong noveldosingstrategyofomalizumabduringmultiallergenoralimmunotherapy
AT natashapurington noveldosingstrategyofomalizumabduringmultiallergenoralimmunotherapy
AT divyakumar noveldosingstrategyofomalizumabduringmultiallergenoralimmunotherapy
AT staceyskura noveldosingstrategyofomalizumabduringmultiallergenoralimmunotherapy
AT margaretawoch noveldosingstrategyofomalizumabduringmultiallergenoralimmunotherapy
AT tiffanytan noveldosingstrategyofomalizumabduringmultiallergenoralimmunotherapy
AT andresalvarez noveldosingstrategyofomalizumabduringmultiallergenoralimmunotherapy
AT rsharonchinthrajah noveldosingstrategyofomalizumabduringmultiallergenoralimmunotherapy
AT mariagarcialloret noveldosingstrategyofomalizumabduringmultiallergenoralimmunotherapy
AT karicnadeau noveldosingstrategyofomalizumabduringmultiallergenoralimmunotherapy
_version_ 1724775561427943424

Similar Items